Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
96 Results Found
340B Advocacy Alliance Bulletin - AHA Files Reply Brief in 340B Case Before the U.S. Supreme Court
The AHA last Friday called the government’s defense of the decision by the Department of Health and Human Services to cut reimbursement to certain hospitals participating in the 340B program by nearly 30% “meritless” as it again urged the U.S. Supreme Court to overturn a lower court decision upholding the agency’s authority to make the cut.
AHA 340B Advocacy Alliance Bulletin: Reminder: Register for AHA 340B Advocacy Alliance Call on Wednesday, Nov. 17
The AHA 340B Advocacy Alliance Wednesday, Nov. 17, at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
AHA 340B Advocacy Alliance Bulletin: Reminder to Register for AHA 340B Advocacy Alliance Call on Nov. 17
The AHA 340B Advocacy Alliance Nov. 17 at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
AHA 340B Advocacy Alliance Bulletin: Register for AHA 340B Advocacy Alliance Call on Nov. 17
The AHA 340B Advocacy Alliance Nov. 17 at 3 p.m. ET will host a special call for AHA 340B hospital members to provide an update on the latest activity on the 340B Drug Pricing Program.
340B Advocacy Alliance Bulletin: Federal District Judge Issues Ruling In Eli Lilly 340B Contract Pharmacy Case
A federal district court judge in Indiana Friday agreed with the government’s contention that the 340B statute would permit the Department of Health and Human Services to require that the drug company Eli Lilly offer 340B discounts for drugs distributed by hospitals through community pharmacies, finding that this was the best reading of the what the 340B statute requires
340B Advocacy Alliance Bulletin: AHA, Other Urge Congressional Leaders to Protect 340B
The AHA and five other groups late Friday expressed continued support for the 340B drug pricing program and strongly encouraged Congress to protect the program as it considers broader changes to the nation’s health care system as part of a legislative package under reconciliation.
340B Advocacy Action Alliance: HRSA Letters to Drug Companies on 340B Community Pharmacy Actions September 22, 2021
HRSA Refers Drug Companies for Enforcement Regarding 340B Community Pharmacy Actions
340B Advocacy Alliance Bulletin: 340B Recertification Deadline Today – Other News and Resources
Advocacy Alliance Bulletin
AHA 340B Advocacy Alliance Bulletin: 340B Comments on OPPS Rule, New Blog
In comments on OPPS proposed rule, AHA continues to oppose 340B cuts The AHA continues to oppose the Centers for Medicare & Medicaid Services’ deep payments cuts to certain 340B hospitals, the association told the agency as part of its comments on the calendar year 2022 outpatient prospective payment system proposed rule.
340B Advocacy Alliance: AHA Urges Congress to Act on 340B Policy; New Fact Sheet Available to Assist with Your Efforts
The AHA last week urged congressional leaders to provide temporary relief for any hospitals participating in the 340B Drug Pricing Program that had to leave the program due to changes in their patient mix as a result of the COVID-19 pandemic.